XU Rui-lian, REN Chong-yang. I-SPY2 Provides The New Trend of Breast Cancer Clinical Trials[J]. Journal of Evidence-Based Medicine, 2017, 17(3): 153-154. DOI: 10.12019/j.issn.1671-5144.2017.03.009
|
Citation:
|
XU Rui-lian, REN Chong-yang. I-SPY2 Provides The New Trend of Breast Cancer Clinical Trials[J]. Journal of Evidence-Based Medicine, 2017, 17(3): 153-154. DOI: 10.12019/j.issn.1671-5144.2017.03.009
|
XU Rui-lian, REN Chong-yang. I-SPY2 Provides The New Trend of Breast Cancer Clinical Trials[J]. Journal of Evidence-Based Medicine, 2017, 17(3): 153-154. DOI: 10.12019/j.issn.1671-5144.2017.03.009
|
Citation:
|
XU Rui-lian, REN Chong-yang. I-SPY2 Provides The New Trend of Breast Cancer Clinical Trials[J]. Journal of Evidence-Based Medicine, 2017, 17(3): 153-154. DOI: 10.12019/j.issn.1671-5144.2017.03.009
|
DownLoad: